Sequent Scientific has informed as they have been approached by certain media houses seeking clarification on the news of observation issued by USFDA on the Company’s plant at Mangalore. In this connection, they wish to confirm that Sequent's facility at Mangalore was inspected by USFDA between Jun 29, 2015 and July 03, 2015 as part of their regular CGMP audit. There was one observation (483s) relating to employee training management processes. The said observation has been attended to and a suitable response has been provided to the USFDA within the stipulated timeline.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: